A Clinical Trial to Investigate the Efficacy of the Brain Blossom Supplement to Improve Cognitive Function and Memory

April 27, 2026 updated by: Bio Nature Health
This study evaluates the efficacy of BioNatureHealth's Brain Blossom supplement in improving cognitive function and memory in adults aged 50-70 years. Participants will be randomized to receive either the test product or placebo over 8 weeks, with cognitive battery testing and questionnaires administered at multiple timepoints.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nevada
      • Las Vegas, Nevada, United States, 89118
        • Citruslabs

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male or female
  • Aged 50-70 years
  • Seeking to support cognitive function and memory
  • Experiences at least three symptoms related to cognitive decline
  • Willing to avoid new cognitive-related medications/supplements
  • Generally healthy

Exclusion Criteria:

  • Medical conditions affecting cognition
  • Psychiatric or neurological disorders
  • Diabetes or heart conditions
  • Use of anticoagulants, benzodiazepines, or pain medications
  • Substance abuse or heavy alcohol use
  • Allergies to product ingredients
  • Inability to comply with protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Brain Blossom Supplement
Participants receive the Brain Blossom supplement daily for 8 weeks.
Six capsules taken once daily in the morning with water.
Placebo Comparator: Placebo
Participants receive placebo capsules daily for 8 weeks.
Rice flour capsules

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Cognitive Battery Composite Score
Time Frame: Baseline, Week 2, Week 4, Week 6, Week 8
Cognitive function and memory will be assessed using a cognitive battery consisting of Polygons, Double Trouble, Feature Match, Paired Associates, Digit Span, and Spatial Planning tasks.
Baseline, Week 2, Week 4, Week 6, Week 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Self-Reported Memory and Recall
Time Frame: Baseline, Week 2, Week 4, Week 6, Week 8
Assessed via study-specific questionnaires evaluating participants' perceived ability to retain and recall information.
Baseline, Week 2, Week 4, Week 6, Week 8
Change in Self-Reported Focus and Attentiveness
Time Frame: Baseline, Week 2, Week 4, Week 6, Week 8
Measured using questionnaire items assessing the ability to concentrate and maintain attention.
Baseline, Week 2, Week 4, Week 6, Week 8
Change in Self-Reported Comprehension
Time Frame: Baseline, Week 2, Week 4, Week 6, Week 8
Assessed via questionnaire responses evaluating participants' perceived ability to understand and process information.
Baseline, Week 2, Week 4, Week 6, Week 8
Change in Self-Reported Mental Clarity
Time Frame: Baseline, Week 2, Week 4, Week 6, Week 8
Measured through questionnaire items assessing clarity of thought and mental sharpness.
Baseline, Week 2, Week 4, Week 6, Week 8
Change in Self-Reported Learning Acuity
Time Frame: Baseline, Week 2, Week 4, Week 6, Week 8
Assessed via questionnaire responses evaluating participants' perceived ability to learn and retain new information.
Baseline, Week 2, Week 4, Week 6, Week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 28, 2025

Primary Completion (Actual)

June 27, 2025

Study Completion (Actual)

June 27, 2025

Study Registration Dates

First Submitted

April 27, 2026

First Submitted That Met QC Criteria

April 27, 2026

First Posted (Actual)

May 4, 2026

Study Record Updates

Last Update Posted (Actual)

May 4, 2026

Last Update Submitted That Met QC Criteria

April 27, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 20737

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Function

Clinical Trials on Dietary Supplement: Brain Blossom

Subscribe